Lv1
44 积分 2026-07-01 加入
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
19小时前
待确认
Characterization of six clinical drugs and dietary intervention in the nonobese CDAA-HFD mouse model of MASH and progressive fibrosis
1个月前
已完结
Human single-stranded DNA binding protein 1 (hSSB1, OBFC2B), a critical component of the DNA damage response
2个月前
已完结
RNA-binding proteins: Post-transcriptional control of aging traits
2个月前
已完结
RNA-binding proteins and their role in kidney disease
2个月前
已完结
皖公网安备34019202002308
